- June 28, 2021
- Posted by: Stratford Team
- Category: Business
GALWAY, Ireland–(BUSINESS WIRE)–Palliare, an emerging company with the vision to create a safer operating room, today announced the closing of an oversubscribed $8 million Series A funding round. The round was led by leading European Life Sciences Venture Capital firm Seroba Life Sciences, with participation from Luxembourg-based SCM AD Ventures, Western Development Commission, and several private investors. The funds will be used to support US commercial launch activities related to Palliare’s EVA15 insufflator and smoke evacuation system, as well as new Research & Development activities.
There has been growing awareness of the hazardous nature of surgical smoke to the operating room staff, and various medical organizations in USA have been lobbying for the safe evacuation of all surgical smoke. The COVID-19 pandemic further heightened awareness across the clinical community of the exposure of medical staff to aerosolized viruses in…